Multivariate AnalysisPrognosisRisk FactorsRetrospective StudiesTreatment OutcomeSurvival AnalysisSurvival RateFollow-Up StudiesProspective StudiesPredictive Value of TestsLogistic ModelsTime FactorsProportional Hazards ModelsCohort StudiesNeoplasm StagingDisease-Free SurvivalAge FactorsKaplan-Meier EstimateCross-Sectional StudiesRegression AnalysisTumor Markers, BiologicalAnalysis of VarianceRisk AssessmentOdds RatioSex FactorsCase-Control StudiesPrevalenceNeoplasm Recurrence, LocalSeverity of Illness IndexQuestionnairesChi-Square DistributionLymphatic MetastasisIncidenceRecurrenceBreast NeoplasmsImmunohistochemistryDisease ProgressionSocioeconomic FactorsUnited StatesBiological MarkersLinear ModelsCombined Modality TherapyROC CurvePostoperative ComplicationsAntineoplastic Combined Chemotherapy ProtocolsReproducibility of ResultsEpidemiologic MethodsAdenocarcinomaComorbidityInfant, NewbornLiver NeoplasmsSmokingLongitudinal StudiesBrazilBody Mass IndexLung NeoplasmsJapanSensitivity and SpecificityRiskNeoplasm InvasivenessHIV InfectionsPrincipal Component AnalysisGenotypeFranceColorectal NeoplasmsModels, StatisticalProbabilityDemographyConfidence IntervalsHospital MortalityRegistriesItalyChemotherapy, AdjuvantTreatment FailureDiscriminant AnalysisCarcinoma, Squamous CellSpainTissue Array AnalysisImmunoglobulin Variable RegionCarcinoma, HepatocellularChinaStatistics as TopicKi-67 AntigenStomach NeoplasmsAcute DiseaseNeoplasm MetastasisChronic DiseasePregnancyAge DistributionMyocardial InfarctionEducational StatusStatistics, NonparametricNeoplasm GradingProstatic NeoplasmsHealth StatusSex DistributionLength of StayAlgorithmsHealth SurveysEuropean Continental Ancestry Group